Latest Breaking News On - Yates network - Page 1 : comparemela.com

Asher Bio Announces Publications in Cancer Discovery Highlighting the Differentiated Profile of AB248, its CD8+ T Cell Selective IL-2 Product Candidate

Asher Bio Announces Publications in Cancer Discovery Highlighting the Differentiated Profile of AB248, its CD8+ T Cell Selective IL-2 Product Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHannah deresiewiczSandy yeungIvana djureticAsher bioKelly moynihanAsher biotherapeuticsDaniela thommenKathryn morrisPaulien kapteinRobert schreiberGroup leaderTeam leader at asher bioDepartment of molecular oncologyWashington university school of medicineYates network

Electra Therapeutics presents first clinical data from ongoing Phase 1b study of ELA026 for treatment of secondary hemophagocytic lymphohistiocytosis (sHLH)

Electra Therapeutics presents first clinical data from ongoing Phase 1b study of ELA026 for treatment of secondary hemophagocytic lymphohistiocytosis (sHLH)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoKathryn morrisSwaminathanp iyerAbhishek maitiKim hien daoHemophagocytic lymphohistiocytosisDepartment of lymphoma myelomaElectra therapeutics incHead of clinical development at electraUniversity of texas md anderson cancer centerDepartment of leukemiaAmerican society of hematologyYates networkAmerican societyResults presented

Electra Therapeutics to Present Clinical Data for ELA026 at the American Society of Hematology (ASH) 2023 Annual Meeting

Electra Therapeutics to Present Clinical Data for ELA026 at the American Society of Hematology (ASH) 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diego convention centerSan diegoKathryn morrisHemophagocytic lymphohistiocytosisYates networkElectra therapeutics incAmerican society of hematologyAmerican societyMonoclonal antibody targeting signal regulatoryNewly diagnosedHallsg hSecondary hemophagocytic lymphohistiocytosisElectra therapeutics

Vaccine Journal Highlights the Potential for Self-Administration of Vaccines Using Vaxxas High-Density Microarray Patch (HD-MAP)

Vaccine Journal Highlights the Potential for Self-Administration of Vaccines Using Vaxxas High-Density Microarray Patch (HD-MAP)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAmy millerDavidl hoeyKathryn morrisOneventures innovation fundYates networkUniversity of queenslandDevelopment authorityAustralian government innovation investment fundUnited states biomedical advanced researchMelinda gates foundationWellcome trustBrandon biocatalystHealthcare venturesAustralian government

Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery

Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEllen cavaleriKathryn morrisRichard niemanHaroldc pillsburyMaria palasisDepartment of otolaryngology headAmerican rhinologic societyYates networkEndoscopic skull base surgeryData presentation at american rhinologic societySchool of medicineDivision of rhinologyCompany quarterly report on formLyra therapeutics incWhile the company